Table 2.
Histological Subtypes Analysis of Ovarian Malignant Tumors
| Histological Subtype | No. of Patients (%) |
|---|---|
| BOT (n=41) | |
| Serous | 23 (56.10) |
| Mucinous | 14 (34.15) |
| Endometrioid | 2 (4.88) |
| Seromucinous | 1 (2.44) |
| Othera | 1 (2.44) |
| EOC (n=18) | |
| Serous | 6 (33.33) |
| Mucinous | 7 (38.89) |
| Primary peritoneal cancer | 2 (11.11) |
| Clear cell | 2 (11.11) |
| Brenner | 1 (5.56) |
| MOGCT (n=14) | |
| Immature teratoma | 7 (50.00) |
| Dysgerminoma | 6 (42.86) |
| Strumal carcinoid | 1 (7.14) |
| MSCT (n=2) | |
| Sertoli-Leydig tumor | 1 (50.00) |
| Granulosa cell tumor | 1 (50.00) |
| SCLC (n=1) | |
| Small cell carcinoma (hypercalcaemic type) | 1 (100.00) |
| Metastatic carcinoma (n=9) | |
| Krukenberg tumor | 7 (77.78) |
| Cervix mixed adenocarcinoma | 1 (11.11) |
| B-cell lymphoma | 1 (11.11) |
Note: aThe patient was diagnosed with bilateral ovarian tumors, including serous borderline ovarian tumor (SBOT) on one side and mucinous borderline ovarian tumor (MBOT) on the other side.
Abbreviations: BOT, borderline ovarian tumor; EOC, epithelial ovarian cancer; MOGCT, malignant ovarian germ cell tumors; MSCT, malignant sex cord-stromal tumors; SCLC, small cell carcinoma.